Back to search

France· FR:66856803

PAXELADINE 0,2 POUR CENT, sirop

A oxeladin product containing citrate d'oxéladine, registered in France by MAYOLY PHARMA FRANCE.

ATC R05DB09

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPAXELADINE 0,2 POUR CENT, siropATCR05DB09REGISTER NO.FR:66856803PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CITRATE D'OXÉLADINE
Manufacturer
MAYOLY PHARMA FRANCE
Country
France (FR)
ATC code
R05DB09
ATC class
Oxeladin
Defined daily dose
80 mg, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400930244418
    1 flacon(s) en verre de 100 ml avec gobelet(s) doseur(s) en polypropylène
  • cip13
    3400932889709
    1 flacon(s) en verre de 125 ml avec cuillère-mesure polystyrène

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c152dd70-8acc-4f00-a191-5ca06639975a
GET /v1/drugs/c152dd70-8acc-4f00-a191-5ca06639975a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66856803",
  "date_amm": "1996-09-20",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CITRATE D'OXÉLADINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "sirop",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about oxeladin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.